MDS, Molecular Devices, PerkinElmer, ABRF, Bruker BioSciences, Biosite, Cellzome, J&J, Ortho-McNeil | GenomeWeb
MDS to Acquire Molecular Devices, Combine with MDS Sciex for New Unit
 
MDS announced this week it has made an offer to buy Molecular Devices for $615 million.
 
The transaction, subject to regulatory approval, would combine Molecular Devices with MDS Sciex, a manufacturer of mass spectrometers and other instruments and technologies, to form a new business unit with more than 1,100 employees including 250 scientists and engineers, the companies said.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.